April 9, 2014 – Bio-Stat LLC, the exclusive US distributor of CELOX hemostatic dressings manufactured by MedTrade Products Ltd., a UK based medical device company, today announced that the US De- partment of Defense’s Committee on Tactical Combat Casualty Care (CoTCCC) has added CELOX Gauze to its guidelines for control of hemorrhage as approved hemostatic agents for military-wide use.
Why CELOX works so well – Why the CoTCCC approved CELOX
CELOX Gauze contains a novel technology that allows it to work on the most severe bleeding where current treatments are not effective. It looks like a simple gauze bandage but has been coated with Celox Granules to give unique properties. In tests conducted by the US Navy, subjects treated with Celox had the highest rate of survival versus those treated with competing products or plain gauze.
Best Results over a wide range of conditions
Combat tested and in use by military forces the world over due to its proven ability to treat a wound with less total blood loss, Celox is the choice for any first response, tactical or emergency wound care. In many of the worst injuries, the blood lost causes the body’s natural clotting abilities to fail, but Celox acts independently of the body’s mechanism and continues to work in this situation, where other treatments that work by accelerating the body’s own clotting process can fail. Celox is also effective under conditions where the patient is using blood thinners or where hypothermia has occurred.
CELOX Products Approved for all US Military Use and Procurement as Emergency Hemostat
Already in use by US Special Forces due to it’s superior results, the approval of the CoTCCC makes CELOX Gauze a standard ordering and procurement hemostatic dressing for all branches of the US military. The CoTCCC decision now makes CELOX available to every member of the DOD’s forces, and CELOX can be added to and reordered for all wound care and medical kits in US military use.
The US military review follows a recent trend in which increasing numbers of civilian emergency services are reviewing their equipment and taking on new treatments. In a large part this is a response to tragedies such as the Boston Marathon bombing as well as new guidelines for responses to indiscriminate shootings. For example, in the Massachusetts area around Boston the regional council for Homeland Security has prescribed new hemorrhage control kits that include the Celox bandages for their responders.
CELOX is exclusively available in the US from BioStat LLC
BioStat LLC, based in Orlando, FL and Medtrade Products Ltd, a UK-based medical devices compa- ny, have an arrangement for all U.S. sales and distribution responsibilities to be handled by BioStat, LLC for the CELOX portfolio of hemostatic agents.
Under terms of the agreement, BioStat has importation, marketing, sales, and distribution oversight responsibility for the entire CELOX portfolio for all military, law enforcement and civilian pre-hospital sales.
Information is available on the internet at http://www.biostatllc.com/, or call 1-844-BIO-STAT for additional details on the CoTCCC approval and how to order CELOX products for use by your unit or agency.
